US › Healthcare

Canopy Growth Corp (CGC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.94+2.57%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$81.2M

Revenue YoY

+12.5%

Net profit

$-14.6M

EPS

$-0.02

EPS estimate

$-0.04

Net margin

-18.0%

EPS came in at -0.02 against a street estimate of -0.04 — a beat of 50.0%.

Key statistics

Market cap

$421.6M

Forward P/E

20.4

P/B

0.79

Book value

$1.17

EPS (TTM)

$-0.49

52-week high

$2.38

52-week low

$0.84

50-day MA

$0.97

200-day MA

$1.08

Beta

2.43

Analyst view

Analysts rate Canopy Growth Corp a hold (2 buy, 4 hold, 4 sell out of 10) with an average price target of $1.22.

Shareholding

Insiders

0.19%

Institutions

7.98%

Largest institutional holders

Fund	Stake
Tidal Investments LLC.	2.00%
Morgan Stanley - Brokerage Accounts	0.47%
Lazard Asset Management LLC	0.44%
Jane Street Group LLC	0.37%
The Goldman Sachs Group Inc	0.30%
Susquehanna International Group, LLP	0.23%
Royal Bank of Canada	0.23%
UBS Group AG	0.22%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Canopy Growth Corp — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.